The management of diabetic wound
healing remains a severe clinical
challenge due to the complicated wound microenvironments, including
abnormal immune regulation, excessive reactive oxygen species (ROS),
and repeated bacterial infections. Herein, we report an extracellular
matrix (ECM)-mimetic coating derived from scallop byssal protein (Sbp9Δ), which can be assembled in situ within
30 min under the trigger of Ca2+ driven by strong coordination
interaction. The biocompatible Sbp9Δ coating and
genetically programmable LL37-fused coating exhibit outstanding antioxidant,
antibacterial, and immune regulatory properties in vitro. Proof-of-concept applications demonstrate that the coating can
reliably promote wound healing in animal models, including diabetic
mice and rabbits, ex vivo human skins, and Staphylococcus aureus-infected diabetic mice. In-depth
mechanism investigation indicates that improved wound microenvironments
accelerated wound repair, including alleviated bacterial infection,
lessened inflammation, appearance of abundant M2-type macrophages,
removal of ROS, promoted angiogenesis, and re-epithelialization. Collectively,
our investigation provides an in situ, convenient,
and effective approach for diabetic wound repair.